Chroma Medicine: Dr. Catherine Stehman-Breen on the Bright Future for Epigenetic Medicine

In 2020, Catherine Stehman-Breen received a call from pioneering biologist and chemist David Liu. "Are you interested in becoming the CEO of an epigenetic editing company?" he asked.

At the time, Catherine, a renowned physician-scientist, was the head of research and development at a cell therapy company. She was intrigued by the budding field of epigenetic editing and its potential to transform the treatment of genetically-driven diseases for patients. Over the past few years, gene editing conversations have started to shift to the related field of epigenetics. Leading scientists continue to explore how new therapeutic approaches to the epigenome — nature's innate mechanism for gene regulation — can preserve genomic integrity, all without nicking or cutting DNA.

Read more: https://www.gv.com/news/chroma-medicine-dr-catherine-stehman-breen

Видео Chroma Medicine: Dr. Catherine Stehman-Breen on the Bright Future for Epigenetic Medicine канала GV (Google Ventures)